The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study-Reference-Cited by-同舟云学术

The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study

Published:2020-09-29 Issue:1 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Moritake Hiroshi¹^ORCID,Tanaka Shiro²,Miyamura Takako³^ORCID,Nakayama Hideki⁴^ORCID,Shiba Norio⁵,Shimada Akira⁶,Terui Kiminori⁷^ORCID,Yuza Yuki⁸,Koh Katsuyoshi⁹,Goto Hiroaki¹⁰,Kakuda Harumi¹¹,Saito Akiko¹²,Hasegawa Daisuke¹³^ORCID,Iwamoto Shotaro¹⁴^ORCID,Taga Takashi¹⁵^ORCID,Adachi Souichi¹⁶,Tomizawa Daisuke¹⁷^ORCID

Affiliation:

1. Division of Pediatrics, Faculty of Medicine University of Miyazaki Miyazaki Japan

2. Department of Clinical Biostatistics, Graduate School of Medicine Kyoto University Kyoto Japan

3. Department of Pediatrics Osaka University Graduate School of Medicine Osaka Japan

4. Department of Pediatrics National Hospital Organization Kyushu Cancer Center Fukuoka Japan

5. Department of Pediatrics Yokohama City University Hospital Yokohama Japan

6. Department of Pediatrics Okayama University Okayama Japan

7. Department of Pediatrics Hirosaki University Graduate School of Medicine Hirosaki Japan

8. Department of Hematology/Oncology Tokyo Metropolitan Children's Medical Center Fuchu Japan

9. Department of Hematology/Oncology Saitama Children's Medical Center Saitama Japan

10. Division of Hemato‐oncology/Regenerative Medicine Kanagawa Children's Medical Center Yokohama Japan

11. Department of Hematology/Oncology Chiba Children's Hospital Chiba Japan

12. Clinical Research Center National Hospital Organization Nagoya Medical Center Nagoya Japan

13. Department of Pediatrics St. Luke's International Hospital Tokyo Japan

14. Department of Pediatrics Mie University Graduate School of Medicine Tsu Japan

15. Department of Pediatrics Shiga University of Medical Science Otsu Japan

16. Department of Human Health Sciences Kyoto University Kyoto Japan

17. Division of Leukemia and Lymphoma Children's Cancer Center National Center for Child Health and Development Tokyo Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28736

Reference26 articles.

1. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

2. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials

3. Improved outcome after relapse in children with acute myeloid leukaemia

4. Outcome in Children With Relapsed Acute Myeloid Leukemia After Initial Treatment With the French Leucémie Aiquë Myéloïde Enfant (LAME) 89/91 Protocol of the French Society of Pediatric Hematology and Immunology

5. Outcome for children with relapsed acute myeloid leukemia in the Netherlands following initial treatment between 1980 and 1998: survival after chemotherapy only?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Horizons in Pediatric Leukemia: Novel Insights, Challenges, and the Journey Ahead;Cureus;2024-08-22

2. Myeloid sarcoma, spectrum of clinical characteristics, prognostic impact, and treatment outcome;Beni-Suef University Journal of Basic and Applied Sciences;2024-08-19

3. Refractory/Relapsed AML in Children and Evolution of Novel Therapies;Pediatric Oncology;2024

4. The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia;Cancers;2023-12-22

5. Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia;Blood Research;2023-11-06